I'm LongbridgeAI, I can summarize articles.QT Imaging Holdings Inc. has secured registration from the Israeli Health Ministry for its Breast Acoustic CT scanner, authorizing commercial sales in Israel until February 2, 2028. This approval, based on existing U.S. FDA clearance, supports the company's international expansion strategy and facilitates a planned clinical study with Rambam Health Care Campus focusing on women at hereditary breast cancer risk.
- QT Imaging won Israeli Health Ministry registration for its Breast Acoustic CT scanner, clearing commercial sales in Israel through Feb. 2, 2028. * Authorization relies on existing U.S. FDA clearance, supporting the company’s international rollout strategy. * Registration also backs a planned clinical study with Rambam Health Care Campus in women with hereditary breast cancer risk. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. QT Imaging Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607280830BIZWIRE_USPR_____20260728_BW975713) on July 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)